Mc Adam, LLC Gilead Sciences, Inc. Transaction History

Mc Adam, LLC

$1.65 Billion
Q2 2024

A detailed history of Mc Adam, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Mc Adam, LLC holds 21,822 shares of GILD stock, worth $1.81 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

21,822

Previous 22,258 1.96%

Holding current value

$1.81 Million

Previous $1.63 Million 8.16%

% of portfolio

0.09%

Previous 0.11%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 24, 2024	SELL	$63.15 - $72.88 $27,533 - $31,775	-436 Reduced 1.96%	21,822 $1.5 Million
Q1 2024 Apr 23, 2024	BUY	$71.58 - $87.29 $908,350 - $1.11 Million	12,690 Added 132.63%	22,258 $1.63 Million
Q4 2023 Feb 05, 2024	SELL	$73.27 - $83.09 $89,682 - $101,702	-1,224 Reduced 11.34%	9,568 $775,000
Q3 2023 Oct 31, 2023	BUY	$73.94 - $80.67 $108,765 - $118,665	1,471 Added 15.78%	10,792 $808,000
Q2 2023 Aug 02, 2023	BUY	$76.01 - $86.7 $4,940 - $5,635	65 Added 0.7%	9,321 $718,000
Q1 2023 Apr 24, 2023	BUY	$77.31 - $88.08 $618 - $704	8 Added 0.09%	9,256 $767,000
Q4 2022 Jan 27, 2023	SELL	$62.32 - $89.47 $68,988 - $99,043	-1,107 Reduced 10.69%	9,248 $671,000
Q3 2022 Oct 24, 2022	BUY	$59.54 - $68.01 $40,368 - $46,110	678 Added 7.01%	10,355 $639,000
Q2 2022 Jul 15, 2022	BUY	$57.72 - $65.01 $33,304 - $37,510	577 Added 6.34%	9,677 $598,000
Q1 2022 Apr 07, 2022	SELL	$57.92 - $72.58 $8,572 - $10,741	-148 Reduced 1.6%	9,100 $541,000
Q4 2021 Jan 07, 2022	BUY	$64.88 - $73.64 $600,010 - $681,022	9,248 New	9,248 $671,000
Q4 2018 Jan 30, 2019	SELL	$60.54 - $79.0 $26,334 - $34,365	-435 Closed	0 $0
Q3 2018 Oct 10, 2018	SELL	$71.28 - $78.92 $13,899 - $15,389	-195 Reduced 30.95%	435 $34,000
Q1 2018 Apr 24, 2018	BUY	$72.84 - $88.8 $45,889 - $55,944	630 New	630 $48,000

Others Institutions Holding GILD

# of Institutions

1,879

Shares Held

1.02B

Call Options Held

12M

Put Options Held

8.96M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $104B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mc Adam, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mc Adam, LLC with notifications on news.

Account